Choroidal imaging using spectral-domain optical coherence tomography

Retina

Volumn 32, Issue 5, 2012, Pages 865-876

  Regatieri, Caio V ^a,b   Branchini, Lauren ^a,c   Fujimoto, James G ^d   Duker, Jay S ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d USA   (United States)

Author keywords

age related macular degeneration; central serous chorioretinopathy; choroid; diabetic retinopathy; optical coherence tomography

Indexed keywords

CENTRAL SEROUS RETINOPATHY; CHOROID; CHOROID DISEASE; CHOROID TUMOR; CHOROIDITIS; DEVICES; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DIAGNOSTIC VALUE; FOLLOW UP; GLAUCOMA; HUMAN; IMAGING SYSTEM; INDOCYANINE GREEN ANGIOGRAPHY; LASER COAGULATION; MEASUREMENT; MORPHOLOGY; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; RETINA DISEASE; RETINA DYSTROPHY; RETINA MACULA AGE RELATED DEGENERATION; RETINITIS PIGMENTOSA; REVIEW; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; THICKNESS; TREATMENT RESPONSE;

CHOROID; CHOROID DISEASES; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; HUMANS; RETINAL DISEASES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84860842183     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318251a3a8     Document Type: Review

References (79)

1. Ryan SJ. Retina. 4th ed. Vol 1. Philadelphia, PA: Elsevier Mosby; 2006:33-34.
2. Cao J, McLeod S, Merges CA, Lutty GA. Choriocapillaris degeneration and related pathologic changes in human diabetic eyes. Arch Ophthalmol 1998;116:589-597. (Pubitemid 28414572)
3. Gemenetzi M, De Salvo G, Lotery AJ. Central serous chorior-etinopathy: an update on pathogenesis and treatment. Eye (Lond) 2010;24:1743-1756.
4. Spaide RF. Age-related choroidal atrophy. Am J Ophthalmol 2009;147:801-810.
5. Torres VL, Brugnoni N, Kaiser PK, Singh AD. Optical coherence tomography enhanced depth imaging of choroidal tumors. Am J Ophthalmol 2011;151:586-593. e582.
6. Maruko I, Iida T, Sugano Y, Saito M, Sekiryu T. Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthal-mol 2011;151:594-603 e1.
7. Inoue R, Sawa M, Tsujikawa M, Gomi F. Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy. Am J Ophthalmol 2010;149:441-446.e441-e442.
8. Shiraki K, Moriwaki M, Kohno T, et al. Age-related scattered hypofluorescent spots on late-phase indocyanine green angio-grams. Int Ophthalmol 1999;23:105-109. (Pubitemid 32041068)
9. Nagaoka T, Kitaya N, Sugawara R, et al. Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes. Br J Ophthalmol 2004;88:1060-1063. (Pubitemid 39013150)
10. Rosen RB, Hathaway M, Rogers J, et al. Simultaneous OCT/SLO/ICG imaging. Invest Ophthalmol Vis Sci 2009;50: 851-860.
11. Spaide RF, Yannuzzi LA, Slakter JS, et al. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculop-athy. Retina 1995;15:100-110.
12. Yannuzzi LA. Indocyanine green angiography: a perspective on use in the clinical setting. Am J Ophthalmol 2011;151: 745-751.e741.
13. Desmettre T, Devoisselle JM, Mordon S. Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography. Surv Ophthalmol 2000;45:15-27. (Pubitemid 30628686)
14. Pemp B, Schmetterer L. Ocular blood flow in diabetes and age-related macular degeneration. Can J Ophthalmol 2008; 43:295-301.
15. Lutty G, Grunwald J, Majji AB, et al. Changes in choriocapil-laris and retinal pigment epithelium in age-related macular degeneration. Mol Vis 1999;5:35.
16. Falsini B, Anselmi GM, Marangoni D, et al. Subfoveal cho-roidal blood flow and central retinal function in retinitis pig-mentosa. Invest Ophthalmol Vis Sci 2011;52:1064-1069.
17. Malhotra A, Minja FJ, Crum A, Burrowes D. Ocular anatomy and cross-sectional imaging of the eye. Semin Ultrasound CT MR 2011;32:2-13.
18. Branchini L, Regatieri CV, Flores-Moreno I, Baumann B, Fujimoto JG, Duker JS. Reproducibility of choroidal thickness measurements across three spectral domain optical coherence tomography systems. Ophthalmology 2012;119:119-123.
19. Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol 2009;147:811-815.
20. Fujiwara T, Imamura Y, Margolis R, et al. Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol 2009;148:445-450.
21. Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the cho-roid in central serous chorioretinopathy. Retina 2009;29: 1469-1473.
22. Manjunath V, Taha M, Fujimoto JG, Duker JS. Choroidal thickness in normal eyes measured using Cirrus HD optical coherence tomography. Am J Ophthalmol 2010;150:325-329.e321.
23. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science 1991;254:1178-1181. (Pubitemid 21917444)
24. Sull AC, Vuong LN, Price LL, et al. Comparison of spectral/Fourier domain optical coherence tomography instruments for assessment of normal macular thickness. Retina 2010;30: 235-245.
25. de Boer JF, Cense B, Park BH, et al. Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography. Opt Lett 2003;28:2067-2069.
26. Leitgeb R, Hitzenberger C, Fercher A. Performance of fourier domain vs. time domain optical coherence tomography. Opt Express 2003;11:889-894.
27. Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthal-mol 2008;146:496-500.
28. Ikuno Y, Maruko I, Yasuno Y, Miura M, Sekiryu T, Nishida K, et al. Reproducibility of retinal and choroidal thickness measurements in enhanced depth imaging and high-penetration optical coherence tomography. Invest Ophthalmol Vis Sci 2011;52: 5536-5540.
29. Nandakumar N, Branchini L, Regatieri CV, et al. Characterization of choroidal morphology in healthy eyes using spectral domain optical coherence tomograph. Invest Ophthalmol Vis Sci 2011;52:E-Abstract 285.
30. Manjunath V, Fujimoto JG, Duker JS. Cirrus HD-OCT high definition imaging is another tool available for visualization of the choroid and provides agreement with the finding that the choroidal thickness is increased in central serous chorioretin-opathy in comparison to normal eyes. Retina 2010;30: 1320-1321; author reply 1321-1322.
31. Kim SW, Oh J, Kwon SS, et al. Comparison of choroidal thickness among patients with healthy eyes, early age-related maculopathy, neovascular age-related macular degeneration, central serous chorioretinopathy, and polypoidal choroidal vas-culopathy. Retina 2011;31:1904-1911.
32. Kim YT, Kang SW, Bai KH. Choroidal thickness in both eyes of patients with unilaterally active central serous chorioretin-opathy. Eye (Lond) 2011;25:1635-1640.
33. Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretin-opathy. Retina 2011;31:1603-1608.
34. Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology 2010;117:1792-1799.
35. Pryds A, Larsen M. Choroidal thickness following extrafoveal photodynamic treatment with verteporfin in patients with central serous chorioretinopathy. Acta Ophthalmol 2011. Epub ahead of print.
36. Maruko I, Iida T, Sugano Y, et al. One-year choroidal thickness results after photodynamic therapy for central serous cho-rioretinopathy. Retina 2011;31:1921-1927.
37. Klein R, Klein BE, Linton KL. Prevalence of age-related mac-ulopathy. The Beaver Dam Eye Study. Ophthalmology 1992; 99:933-943.
38. Fung AE, Lalwani GA, Rosenfeld PJ, et al. An optical coherence tomography-guided, variable dosing regimen with intra-vitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 2007;143:566-583.
39. Koizumi H, Yamagishi T, Yamazaki T, Kawasaki R, Kinoshita S. Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vas-culopathy. Graefes Arch Clin Exp Ophthalmol 2011;249: 1123-1128.
40. Hidayat AA, Fine BS. Diabetic choroidopathy. Light and electron microscopic observations of seven cases. Ophthalmology 1985;92:512-522. (Pubitemid 15034524)
41. Weinberger D, Kramer M, Priel E, et al. Indocyanine green angiographic findings in nonproliferative diabetic retinopathy. Am J Ophthalmol 1998;126:238-247. (Pubitemid 28397097)
42. Esmaeelpour M, Povazay B, Hermann B, Hofer B, Kajic V, Hale SL, et al. Mapping choroidal and retinal thickness variation in type 2 diabetes using three-dimensional 1060-nm optical coherence tomography. Invest Ophthalmol Vis Sci 2011; 52:5311-5316.
43. Schocket LS, Brucker AJ, Niknam RM, et al. Foveolar choroi-dal hemodynamics in proliferative diabetic retinopathy. Int Ophthalmol 2004;25:89-94. (Pubitemid 38801845)
44. Shiragami C, Shiraga F, Matsuo T, et al. Risk factors for diabetic choroidopathy in patients with diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2002;240:436-442. (Pubitemid 36104154)
45. Gupta V, Gupta A, Gupta P, Sharma A. Spectral-domain cirrus optical coherence tomography of choroidal striations seen in the acute stage of Vogt-Koyanagi-Harada disease. Am J Oph-thalmol 2009;147:148-153.e142.
46. Diniz B, Regatieri C, Andrade R, Maia A. Evaluation of spectral domain and time domain optical coherence tomography findings in toxoplasmic retinochoroiditis. Clin Ophthalmol 2011;5:645-650.
47. Bordaberry MF. Vogt-Koyanagi-Harada disease: diagnosis and treatments update. Curr Opin Ophthalmol 2010;21:430-435.
48. Herbort CP, Mantovani A, Bouchenaki N. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up. Int Ophthalmol 2007;27: 173-182. (Pubitemid 46909258)
49. Fong AH, Li KK, Wong D. Choroidal evaluation using enhanced depth imaging spectral-domain optical coherence tomography in Vogt-Koyanagi-Harada disease. Retina 2011; 31:502-509.
50. Yasuno Y, Okamoto F, Kawana K, et al. Investigation of mul-tifocal choroiditis with panuveitis by three-dimensional high-penetration optical coherence tomography. J Biophotonics 2009;2:435-441.
51. Vance SK, Khan S, Klancnik JM, Freund KB. Characteristic spectral-domain optical coherence tomography findings of multifocal choroiditis. Retina 2011;31:717-723.
52. Freton A, Finger PT. Spectral domain-optical coherence tomography analysis of choroidal osteoma. Br J Ophthalmol 2012;96: 224-228.
53. Say EA, Shah SU, Ferenczy S, Shields CL. Optical coherence tomography of retinal and choroidal tumors. J Ophthalmol 2010;2011:385058.
54. Witkin AJ, Ko TH, Fujimoto JG, et al. Ultra-high resolution optical coherence tomography assessment of photoreceptors in retinitis pigmentosa and related diseases. Am J Ophthalmol 2006;142:945-952.
55. Yeoh J, Rahman W, Chen F, et al. Choroidal imaging in inherited retinal disease using the technique of enhanced depth imaging optical coherence tomography. Graefes Arch Clin Exp Ophthal-mol 2010;248:1719-1728.
56. Ho J, Branchini L, Regatieri C, et al. Analysis of normal peri-papillary choroidal thickness via spectral domain optical coherence tomography. Ophthalmology 2011;118:2001-2007.
57. Maul EA, Friedman DS, Chang DS, et al. Choroidal thickness measured by spectral domain optical coherence tomography: factors affecting thickness in glaucoma patients. Ophthalmology 2011;118:1571-1579.
58. Mwanza JC, Hochberg JT, Banitt MR, et al. Lack of association between glaucoma and macular choroidal thickness measured with enhanced depth-imaging optical coherence tomography. Invest Ophthalmol Vis Sci 2011;52:3430-3435.
59. Ehrlich JR, Peterson J, Parlitsis G, et al. Peripapillary choroidal thickness in glaucoma measured with optical coherence tomography. Exp Eye Res 2011;92:189-194.
60. Usui S, Ikuno Y, Miki A, et al. Evaluation of the choroidal thickness using high-penetration optical coherence tomography with long wavelength in highly myopic normal-tension glaucoma. Am J Ophthalmol 2011. Epub ahead of print.
61. Park SC, De Moraes CG, Teng CC, Tello C, Liebmann JM, Ritch R. Enhanced depth imaging optical coherence tomography of deep optic nerve complex structures in glaucoma. Ophthalmology 2012;119:3-9.
62. Unterhuber A, Povazay B, Hermann B, et al. In vivo retinal optical coherence tomography at 1040 nm\enhanced penetration into the choroid. Opt Express 2005;13:3252-3258. (Pubitemid 40899376)
63. Povazay B, Bizheva K, Hermann B, et al. Enhanced visualization of choroidal vessels using ultrahigh resolution ophthalmic OCT at 1050 nm. Opt Express 2003;11:1980-1986.
64. Povazay B, Hermann B, Unterhuber A, et al. Three-dimensional optical coherence tomography at 1050 nm versus 800 nm in retinal pathologies: enhanced performance and choroidal penetration in cataract patients. J Biomed Opt 2007;12:041211.
65. Chinn SR, Swanson EA, Fujimoto JG. Optical coherence tomography using a frequency-tunable optical source. Opt Lett 1997;22:340-342. (Pubitemid 127581717)
66. de Boer JF, Milner TE, van Gemert MJ, Nelson JS. Two-dimensional birefringence imaging in biological tissue by polarization-sensitive optical coherence tomography. Opt Lett 1997;22:934-936. (Pubitemid 127561994)
67. Drexler W, Fujimoto JG. State-of-the-art retinal optical coherence tomography. Prog Retin Eye Res 2008;27:45-88. (Pubitemid 351165776)
68. Choma MA, Yang C, Izatt JA. Instantaneous quadrature low-coherence interferometry with 3 x 3 fiber-optic couplers. Opt Lett 2003;28:2162-2164.
69. Choma MA, Hsu K, Izatt JA. Swept source optical coherence tomography using an all-fiber 1300-nm ring laser source. J Biomed Opt 2005;10:44009.
70. Srinivasan VJ, Huber R, Gorczynska I, et al. High-speed, high-resolution optical coherence tomography retinal imaging with a frequency-swept laser at 850 nm. Opt Lett 2007;32: 361-363. (Pubitemid 46354023)
71. Huber R, Adler DC, Srinivasan VJ, Fujimoto JG. Fourier domain mode locking at 1050 nm for ultra-high-speed optical coherence tomography of the human retina at 236,000 axial scans per second. Opt Lett 2007;32:2049-2051. (Pubitemid 351389970)
72. Izatt JA, Kulkarni MD, Yazdanfar S, et al. In vivo bidirectional color Doppler flow imaging of picoliter blood volumes using optical coherence tomography. Opt Lett 1997;22: 1439-1441. (Pubitemid 127565229)
73. Leitgeb R, Schmetterer L, Drexler W, et al. Real-time assessment of retinal blood flow with ultrafast acquisition by color Doppler Fourier domain optical coherence tomography. Opt Express 2003;11:3116-3121.
74. White B, Pierce M, Nassif N, et al. In vivo dynamic human retinal blood flow imaging using ultra-high-speed spectral domain optical coherence tomography. Opt Express 2003;11:3490-3497.
75. Wang Y, Lu A, Gil-Flamer J, et al. Measurement of total blood flow in the normal human retina using Doppler Fourier-domain optical coherence tomography. Br J Ophthalmol 2009;93: 634-637.
76. Leitgeb RA, Schmetterer L, Hitzenberger CK, et al. Real-time measurement of in vitro flow by Fourier-domain color Doppler optical coherence tomography. Opt Lett 2004;29:171-173.
77. Makita S, Hong Y, Yamanari M, et al. Optical coherence angiography. Opt Express 2006;14:7821-7840. (Pubitemid 44277517)
78. Miura M, Makita S, Iwasaki T, Yasuno Y. Three-dimensional visualization of ocular vascular pathology by optical coherence angiography in vivo. Invest Ophthalmol Vis Sci 2011. Epub ahead of print.
79. Srinivasan VJ, Adler DC, Chen Y, et al. Ultrahigh-speed optical coherence tomography for three-dimensional and en face imaging of the retina and optic nerve head. Invest Oph-thalmol Vis Sci 2008;49:5103-5110.